FDA commissioner Marty Makary faces possible dismissal amid political pressure, while new insights link menstrual cycles to mental health

Theresa Gaffney’s Morning Rounds newsletter highlighted a growing body of research that connects menstrual cycle patterns with fluctuations in mental health, underscoring the importance of gender‑specific considerations in psychiatric care.

Separate reports indicate that President Trump has approved a plan to remove FDA Commissioner Marty Makary from his post. Makary, who has served just over a year, has been described as ambitious but controversial, and his recent absence from a scheduled public appearance has fueled speculation about his departure.

The briefing also noted an upcoming Supreme Court deadline concerning the abortion medication mifepristone, adding another layer of legal uncertainty to the reproductive‑health landscape.

Overall, the newsletter combined scientific updates with political developments that could shape health policy in the coming months.